Cargando…
Evaluation of Anti-Mullerian Hormone Levels, Antral Follicle Counts, and Mean Ovarian Volumes in Chemotherapy-Induced Amenorrhea among Breast Cancer Patients: A Prospective Clinical Study
Estradiol (E2), a follicle-stimulating hormone (FSH), AMH, and inhibin B levels, along with AFC and MOV, are used to determine ovarian reserve in pre-menopausal women. Studies have shown that AMH levels are more sensitive than those of E2, FSH, and inhibin B and that AFC and MOV can be used to evalu...
Autores principales: | Ünal, Çağlar, Ordu, Çetin, Özmen, Tolga, İlgun, Ahmet Serkan, Çelebi, Filiz, Baysal, Bülent, Özkurt, Enver, Duymaz, Tomris, Erdoğan İyigün, Zeynep, Kurt, Sevgi, Öztürk, Mehmet Alper, Pilancı, Kezban Nur, Alço, Gül, Yararbaş, Kanay, Kayan Tapan, Tuba, Güven, Deniz Can, Soybir, Gürsel, Özmen, Vahit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605884/ https://www.ncbi.nlm.nih.gov/pubmed/37887566 http://dx.doi.org/10.3390/curroncol30100666 |
Ejemplares similares
-
MCM-2 Levels as a Potential Biomarker for Predicting High-Risk Breast Cancer Patients According to TAILORx Classification
por: Ünal, Çağlar, et al.
Publicado: (2023) -
Survival results according to Oncotype Dx recurrence score in patients with hormone receptor positive HER-2 negative early-stage breast cancer: first multicenter Oncotype Dx recurrence score survival data of Turkey
por: Ünal, Çağlar, et al.
Publicado: (2023) -
Comparison of breast cancer patients who underwent partial mastectomy (PM) with mini latissimus dorsi flap (MLDF) and subcutaneous mastectomy with implant (M + I) regarding quality of life (QOL), cosmetic outcome and survival rates
por: Ozmen, Vahit, et al.
Publicado: (2020) -
LONG-TERM SURVIVAL EFFECTS OF PREOPERATIVE BREAST MRI IN PATIENTS WITH BREAST-CONSERVING SURGERY
por: Ilgun, Ahmet Serkan, et al.
Publicado: (2022) -
Importance of multigene panel test in patients with consanguineous marriage and family history of breast cancer
por: Ozmen, Vahit, et al.
Publicado: (2022)